Hält derzeit eine Position bei Collegium Pharmaceutical Inc
Position | Company | Period |
---|---|---|
Executive Vice President, Chief Commercial Officer | Collegium Pharmaceutical Inc | 1. August 2018 - |
Senior Vice President of Sales, Marketing and Training | Collegium Pharmaceutical Inc | 1. Januar 2018 - 1. August 2018 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-28 | 2024-02-26 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
664
-0.5%
37,1524.670 USD |
664 -0.5% | 37,15 | 24.670 USD | |
2024-02-28 | 2024-02-26 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
9.336
-6.3%
36,38339.601 USD |
9.336 -6.3% | 36,38 | 339.601 USD | |
2024-01-18 | 2024-01-16 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
23.560
-17.5%
32,28760.519 USD |
23.560 -17.5% | 32,28 | 760.519 USD | |
2023-03-03 | 2023-03-01 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
13.324
-9.0%
26,70355.751 USD |
13.324 -9.0% | 26,70 | 355.751 USD | |
2023-01-11 | 2023-01-09 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
69
-0.1%
28,581.972 USD |
69 -0.1% | 28,58 | 1.972 USD | |
2023-01-11 | 2023-01-09 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
7.341
-6.7%
27,83204.300 USD |
7.341 -6.7% | 27,83 | 204.300 USD | |
2023-01-11 | 2023-01-09 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
10.424
-8.6%
27,08282.282 USD |
10.424 -8.6% | 27,08 | 282.282 USD | |
2022-02-28 | 2022-02-18 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
10.559
-8.0%
21,61228.180 USD |
10.559 -8.0% | 21,61 | 228.180 USD | |
2021-12-17 | 2021-12-15 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
5.693
-6.9%
18,33104.353 USD |
5.693 -6.9% | 18,33 | 104.353 USD | |
2021-02-12 | 2021-02-11 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
5.798
-6.5%
25,33146.863 USD |
5.798 -6.5% | 25,33 | 146.863 USD | |
2021-02-12 | 2021-02-11 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
2.100
-2.3%
24,8952.269 USD |
2.100 -2.3% | 24,89 | 52.269 USD | |
2021-01-20 | 2021-01-15 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
1.322
-2.9%
22,8930.261 USD |
1.322 -2.9% | 22,89 | 30.261 USD | |
2020-07-14 | 2020-07-13 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
1.429
-3.0%
17,0124.307 USD |
1.429 -3.0% | 17,01 | 24.307 USD | |
2020-05-20 | 2020-05-18 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
8.000
-14.2%
24,00192.000 USD |
8.000 -14.2% | 24,00 | 192.000 USD | |
2020-05-15 | 2020-05-13 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
4.434
-8.4%
22,61100.253 USD |
4.434 -8.4% | 22,61 | 100.253 USD | |
2020-01-16 | 2020-01-14 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
1.321
-3.6%
23,8731.532 USD |
1.321 -3.6% | 23,87 | 31.532 USD | |
2019-07-12 | 2019-07-11 |
Collegium Pharmaceutical Inc
(COLL)
|
GV Geplanter Verkauf |
2.857
-7.0%
12,3135.170 USD |
2.857 -7.0% | 12,31 | 35.170 USD |